Detalles de la búsqueda
1.
Vismodegib in Locally Advanced Basal Cell Carcinoma in Slovenia.
Dermatology
; 239(1): 158-164, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-35896082
2.
Ocular Changes in Metastatic Melanoma Patients Treated with MEK Inhibitor Cobimetinib and BRAF Inhibitor Vemurafenib.
Radiol Oncol
; 52(2): 213-219, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30018526
3.
Recommendations for the Prophylactic Management of Skin Reactions Induced by Epidermal Growth Factor Receptor Inhibitors in Patients With Solid Tumors.
Oncologist
; 21(12): 1483-1491, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27449521
4.
Malignant gliomas: old and new systemic treatment approaches.
Radiol Oncol
; 50(2): 129-38, 2016 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27247544
5.
Bevacizumab plus chemotherapy in elderly patients with previously untreated metastatic colorectal cancer: single center experience.
Radiol Oncol
; 50(2): 226-31, 2016 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27247556
6.
The cost of systemic therapy for metastatic colorectal carcinoma in Slovenia: discrepancy analysis between cost and reimbursement.
Radiol Oncol
; 49(2): 200-8, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26029033
7.
Bevacizumab and irinotecan in recurrent malignant glioma, a single institution experience.
Radiol Oncol
; 49(1): 80-5, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25810706
8.
Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial.
Lancet Oncol
; 14(11): 1077-1085, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24028813
9.
Prognostic factors for overall survival and safety of trans-arterial chemoembolization (TACE) with irinotecan-loaded drug-eluting beads (DEBIRI) in patients with colorectal liver metastases.
Radiol Oncol
; 58(2): 214-220, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38553252
10.
A review of the treatment options for skin rash induced by EGFR-targeted therapies: Evidence from randomized clinical trials and a meta-analysis.
Radiol Oncol
; 47(2): 166-75, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23801914
11.
The correlation between the levels of tissue inhibitor of metalloproteinases 1 in plasma and tumour response and survival after preoperative radiochemotherapy in patients with rectal cancer.
Radiol Oncol
; 47(2): 138-44, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23801910
12.
The five-year KRAS, NRAS and BRAF analysis results and treatment patterns in daily clinical practice in Slovenia in 1st line treatment of metastatic colorectal (mCRC) patients with RAS wild-type tumour (wtRAS) - a real- life data report 2013-2018.
Radiol Oncol
; 57(1): 103-110, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36942906
13.
Biomarkers for Outcome in Metastatic Melanoma in First Line Treatment with Immune Checkpoint Inhibitors.
Biomedicines
; 11(3)2023 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36979727
14.
The Prognostic and Predictive Value of Human Gastrointestinal Microbiome and Exosomal mRNA Expression of PD-L1 and IFNγ for Immune Checkpoint Inhibitors Response in Metastatic Melanoma Patients: PROTOCOL TRIAL.
Biomedicines
; 11(7)2023 Jul 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37509655
15.
Impact of the specific mutation in KRAS codon 12 mutated tumors on treatment efficacy in patients with metastatic colorectal cancer receiving cetuximab-based first-line therapy: a pooled analysis of three trials.
Oncology
; 83(5): 241-7, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22948721
16.
Choroidal thickening with serous retinal detachment in BRAF/MEK inhibitor-induced uveitis: A case report.
World J Clin Cases
; 10(19): 6536-6542, 2022 Jul 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35979276
17.
Adverse events during immunotherapy in Slovenian patients with metastatic melanoma reveal a positive correlation with better treatment outcomes.
Radiol Oncol
; 55(3): 354-361, 2021 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33939899
18.
Retrospective analysis of treatment-naive Slovenian patients with metastatic melanoma treated with pembrolizumab - real-world experience.
Radiol Oncol
; 54(1): 119-127, 2020 01 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31955148
19.
Capecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic colorectal cancer: a randomised prospective phase II trial.
BMC Cancer
; 9: 120, 2009 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-19386096
20.
Molecular biomarkers and histological parameters impact on survival and response to first- line systemic therapy of metastatic colorectal cancer patients.
Radiol Oncol
; 53(1): 85-95, 2019 03 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30840593